Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: A population-based case-control study in the five Nordic countries-Reference-Cited by-同舟云学术

Radiation dose and relapse are predictors for development of second malignant solid tumors after cancer in childhood and adolescence: A population-based case-control study in the five Nordic countries

Published:2006-01 Issue:4 Volume:45 Page:438-448
ISSN:0284-186X
Container-title:Acta Oncologica
language:en
Short-container-title:Acta Oncologica

Author:

Svahn-Tapper Gudrun,Garwicz Stanislaw,Anderson Harald,Shamsaldin Akthar,De Vathaire Florent,Olsen Jørgen H.,Døllner Henrik,Hertz Henrik,Jonmundsson Gudmundur,Langmark Frøydis,Lanning Marjatta,Sankila Risto,Tulinius Hrafn,Möller Torgil

Publisher

Informa UK Limited

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/02841860600658633

Reference45 articles.

1. Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983

2. Second cancers following pediatric Hodgkin's disease.

3. Second Malignant Neoplasms After Treatment for Hodgkin’s Disease in Childhood or Adolescence

4. Melanoma as a second malignant neoplasm after childhood cancer

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiation-Related Thyroid Cancer;Endocrine Reviews;2023-07-14

2. Equivalent doses for anticancer agents used in pediatric oncology: A literature review and evaluation of a novel approach for conversion factors;Cancer Reports;2023-03-28

3. Pooled Analysis of Meningioma Risk Following Treatment for Childhood Cancer;JAMA Oncology;2022-12-01

4. Out-of-field organ doses and associated risk of cancer development following radiation therapy with photons;Physica Medica;2021-10

5. Cancer predisposition syndromes as a risk factor for early second primary neoplasms after childhood cancer – A national cohort study;European Journal of Cancer;2021-03